Healio

Patient-favored discontinuation improved with Entyvio, Stelara in IBD

Please provide your email address to receive an email when new articles are posted on . Patient preference favoring treatment discontinuation was improved during treatment with Entyvio or Stelara ...
Healio

FDA approves Selarsdi as Stelara biosimilar for psoriasis, psoriatic arthritis

Please provide your email address to receive an email when new articles are posted on . Selarsdi is approved for the treatment of plaque psoriasis, psoriatic arthritis in adults, patients aged 6 years ...
Pharmabiz

Janssen's Stelara gets European approval to treat adult patients with Crohn’s disease

Janssen-Cilag International NV (Janssen) announced that the European Commission (EC) has approved the use of Stelara (ustekinumab) for the treatment of adult patients with moderately to severely ...
The Reporter

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn’s Disease

SPRING HOUSE, Pa., May 23, 2021 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA (R) (ustekinumab) in Crohn’s disease (CD) ...
WDAF-TV

STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis

As the first and only biologic targeting both cytokines interleukin (IL)-12 and IL-23, STELARA provides a new therapeutic option for children six years of age and older living with active psoriatic ...
JD Supra

FDA Approves Amgen’s WEZLANA As Biosimilar to and Interchangeable With Janssen’s STELARA (ustekinumab)

On Tuesday, October 31, FDA approved Amgen’s WEZLANA (ustekinumab-auub) as biosimilar to and interchangeable with Janssen’s STELARA (ustekinumab). WEZLANA is the first product to be approved as a ...